Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 41 of 151

  1. Chemotherapy + immunotherapy

    Hunan Province Tumor Hospital

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  2. Chemotherapy plus apatinib

    Lei Li

    Recurrent Cervical Carcinoma

    phase 2 small molecule completed

    1 trial

  3. Chemotherapy+PD-1 inhibitor+8Gy x 3f

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HR+HER2- Breast Cancer

    phase 2 small molecule active

    1 trial

  4. Chidamide

    Biotech Pharmaceutical Co.,

    Relapsed or Refractory Peripheral T-cell Lymphoma

    phase 2 small molecule active

    1 trial

  5. Chidamide

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    phase 2 small molecule active

    2 trials

  6. Chidamide

    Sun Yat-sen University

    Peripheral T-cell Lymphoma

    phase 2 small molecule active

    1 trial

  7. Chidamide

    Biotech Pharmaceutical Co.,

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule terminated

    1 trial

  8. Chidamide + Tislelizumab + chemotherapy (CapeOX )

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colon Adenocarcinoma

    phase 2 small molecule active

    1 trial

  9. Chidamide Combined with NKG2D CAR-NK Cell Therapy

    The First People's Hospital of Lianyungang

    HIV (Human Immunodeficiency Virus)

    phase 2 small molecule active

    1 trial

  10. Chidamide combined with Duvillisib

    The First People's Hospital of Lianyungang

    Peripheral T Cell Lymphoma

    phase 2 small molecule active

    1 trial

  11. Chinese Herb

    Chinese University of Hong Kong

    COVID-19

    phase 2 small molecule active

    1 trial

  12. Chinese Herb Astragalus membranaceus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 2 small molecule completed

    1 trial

  13. Chinese Medicine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Mountain Sickness (AMS)

    phase 2 small molecule active

    1 trial

  14. Chinese Medicine Oral Rinse Formula-I (CMORF-I)

    Chinese University of Hong Kong

    Head and Neck Neoplasms

    phase 2 small molecule active

    1 trial

  15. Chinese herbal concoction twice a day for 6 months

    Universal Integrated

    Myelodysplastic Syndrome (MDS)

    phase 2 small molecule completed

    1 trial

  16. Chinese herbal therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Urinary Incontinence, Stress

    phase 2 other completed

    1 trial

  17. Chinese herbs-I

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mycobacterium Abscessus Pulmonary Disease

    phase 2 small molecule active

    1 trial

  18. Chlorambucil

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 2 small molecule terminated

    1 trial

  19. Cholecalciferol

    Hospital Authority, Hong Kong

    Hematologic Neoplasms

    phase 2 small molecule active

    1 trial

  20. ChronVac-C + SOC

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis C

    phase 2 small molecule active

    1 trial

  21. Chronocort

    NEUROCRINE BIOSCIENCES INC

    Primary Adrenal Insufficiency

    phase 2 small molecule completed

    1 trial

  22. Ciclosporin

    United Therapeutics Europe Ltd

    Myocardial Reperfusion Injury

    phase 2 small molecule completed

    1 trial

  23. Cigarettes with varying nicotine content

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 other completed

    1 trial

  24. Cinryze powder and solvent for solution for i... for Traumatic Brain Injury

    Disc Medicine

    Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  25. Ciprofloxacin

    United Therapeutics Europe Ltd

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  26. Cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    phase 2 small molecule active

    1 trial

  27. Cisplatin

    Ultragenyx UK Limited

    Squamous Cell Carcinoma of the Anus

    phase 2 small molecule active

    1 trial

  28. Cisplatin Accord Healthcare /ml concentraat v... for Vulvar cancer

    Disc Medicine

    Vulvar cancer

    phase 2 small molecule active

    1 trial

  29. Cisplatin and Doxorubicin

    Chinese University of Hong Kong

    Gastric Cancer Peritoneal Metastases

    phase 2 small molecule active

    1 trial

  30. Cisplatin+Capecitabine+Sintilimab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  31. Citalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    3 trials

  32. Cizutamig

    Lacuna Pharma Pty Ltd

    Severe, treatment refractory primary Sjögren’s disease (pSjD), Severe, treatment refractory idiopathic inflammatory myopathy (IIM), Severe, treatment refractory systemic sclerosis (SSc), Severe, treatment-refractory, seropositive (anti-citrullinated protein antibody (ACPA) and/or rheumatoid factor positive) rheumatoid arthritis (RA)

    phase 2 small molecule active

    1 trial

  33. Clarithromycin

    Takeda

    Myeloma

    phase 2 small molecule active

    1 trial

  34. Claseprubart

    Dianthus Therapeutics, Inc. /DE/

    Multifocal Motor Neuropathy

    phase 2 small molecule active

    1 trial

  35. Clifutinib Besylate

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Myeloid Leukemia, Adult

    phase 2 small molecule active

    1 trial

  36. Clobetasol Propionate

    United Therapeutics Europe Ltd

    Colon Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  37. Clonazepam

    BRIGHT MINDS BIOSCIENCES INC.

    REM Sleep Behavior Disorder

    phase 2 small molecule completed

    1 trial

  38. Clonazepam

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 2 small molecule completed

    1 trial

  39. Clonazepam

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 2 small molecule completed

    1 trial

  40. Clonidine

    Grace Therapeutics

    Pregnancy Related

    phase 2 small molecule completed

    1 trial

  41. Clonidine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  42. Clostridium Butyricum Tablets

    The First People's Hospital of Lianyungang

    Bladder (Urothelial, Transitional Cell) Cancer

    phase 2 small molecule active

    1 trial

  43. Coagulation Factor IX variant

    CATALYST PHARMACEUTICALS, INC.

    Hemophilia B

    phase 2 mab completed

    1 trial

  44. Coagulation Factor VIIa variant

    CATALYST PHARMACEUTICALS, INC.

    Factor VII Deficiency

    phase 2 mab terminated

    1 trial

  45. Coagulation Factor VIIa variant

    CATALYST PHARMACEUTICALS, INC.

    Hemophilia A With Inhibitor

    phase 2 mab completed

    1 trial

  46. Cobimetinib

    Hoffmann-La Roche

    Solid Tumors

    phase 2 small molecule completed

    1 trial

  47. Coenzyme Q10

    United Therapeutics Europe Ltd

    Charcot Marie Tooth Disease

    phase 2 small molecule completed

    1 trial

  48. Cognitive Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.